Tempus Founder Eric Lefkofsky Makes Strides in Using Big Data for Cancer Treatment Plans

Eric Lefkofsky is a very interesting man to follow. His career trajectory spans everything from the startup of legendary game changer Groupon, to the incredible Uptake Technologies that is now valued at over $2 billion, to Lightbank – a new type of investment firm that focuses on disruptive technologies and more information click here.

Lefkofsky has done incredible things in disrupting how we do things by utilizing new technologies. He is known globally as an innovator and a disruptor in a variety of industries. With his latest venture, Tempus he is now known for using technology to change the way that oncologists are able to map out cancer treatments for their patients by utilizing genomic data.

The goal of Tempus is to build the world largest’s operating system that will organize a wealth of both clinical and genomic data into a single digitized system. This system will be able to be accessed by any oncologist or their team throughout the world and what Eric knows.

While there is a great amount of data collected from each cancer patient’s treatment, it is often housed in physician’s notes, which are filed in each hospital or treatment center. Lefkofsky realized that there is no central source that houses this informations so that oncologists can access the data from other hospitals and clinics. And thus, Tempus was born and Eric on Facebook.

Tempus recently announced that it had received $70 million in a series C funding around that launched it to a total of $130 million in total funding. This is a great feat since the company was only founded in 2015. It has seen major success including partnering with multiple elite clinics such as the Cleveland Clinic, the Mayo Clinic and Duke’s Medical Center and Eric’s lacrosse camp.

Tempus recently received an evaluation of over $700 million and continues to see rapid growth within both the established medical community and the startup community. By continuing to grow see scalable growth, Tempus is truly making strides in helping oncologists to use machine learning algorithms and the collection of big data to provide their patients with a fully customized treatment based around genome mapping.

Tempus is proof of how the power of technology can be used to make new strides in the medical field, especially as it related to cancer.

More Visit: https://www.tempus.com/about-us/

Leave a Reply

Your email address will not be published. Required fields are marked *